Arovella Therapeutics Ltd. announced that effective 6 December 2023, the Company's Registered Office and Principal Place of Business has changed to: Corporate Once, 84 Hotham Road, Preston, VIC 3072 Australia.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 AUD | -4.00% | 0.00% | +4.35% |
26/03 | Arovella Therapeutics Receives Firm Commitments for About AU$12.5 Million Raise | MT |
20/03 | Arovella Therapeutics' ALA-101-onCARlytics Collaboration with Imugene Ends; Shares Down 12% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.35% | 86.74M | |
+23.37% | 47.02B | |
+49.96% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- ALA Stock
- News Arovella Therapeutics Limited
- Arovella Therapeutics Ltd. Announces Change of Company Address